VeriMombuxus sempervirens leaf extract est-il sûr pendant la grossesse ?
No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
Related ingredients
Frequently asked questions
- buxus sempervirens leaf extract est-il sûr pendant la grossesse ?
- No EU restriction or ban listed for Buxus sempervirens extract in the EU cosmetics inventory (INCI entry present), and there are no SCCS or CIR safety assessments or harmonised CLP (Annex VI) CMR classifications identified for the cosmetic extract. Published toxicology about Buxus species reports steroidal alkaloids (e.g., cyclobuxine) that cause systemic toxicity after ingestion, but I did not find peer‑reviewed reproductive or developmental studies on the cosmetic leaf extract showing teratogenicity or reproductive effects; therefore hazard = 0 and mechanism = 0. Topical cosmetic exposure is expected to be low but measurable, so exposure = 1.
- buxus sempervirens leaf extract est-il sûr pendant l'allaitement ?
- Same evidence base as for pregnancy: no regulatory bans/restrictions (EU Annex II/III), no harmonised H361/H360 classification, and no breastfeeding‑specific toxicity or transfer data for the cosmetic leaf extract. Ingestion of whole plant is known to be toxic (steroidal alkaloids), but that does not constitute evidence of reproductive/lactation hazard from topical cosmetic use; exposure from dermal use is low but measurable.
- buxus sempervirens leaf extract est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental toxicity data were identified for the cosmetic extract. Because infant skin has a higher surface‑area‑to‑body‑weight ratio and an immature barrier, I increased exposure by +1 relative to the adult dermal exposure score; there is still no evidence of a reproductive mechanism or harmonised classification for the cosmetic ingredient itself.
- Comment VeriMom évalue-t-il buxus sempervirens leaf extract ?
- VeriMom évalue buxus sempervirens leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à buxus sempervirens leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à buxus sempervirens leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.